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1. Motivation and aim of the study 
Mesenchymal stem cells (MSC) are known for their self-renewal and multilineage differentiation po-
tential. This makes them a promising tool for cell therapies in regenerative medicine to improve the 
healing of damaged tissue. The regenerative potential of these cells is shown in various studies, i.e. they 
have been used to treat chronic wounds, skeletal diseases, injured myocardium, defects in articular car-
tilage and intervertebral disc [1–4]. In recent years, also the immunomodulatory properties of these cells 
have been shown. There are several clinical trials to treat immune- and inflammation-mediated diseases 
with MSC, i.e. multiple sclerosis, type 1 diabetes mellitus, graft versus host disease, osteoarthritis and 
inflammatory bowel disease [5]. 
Wound infections due to bacteria are common post-operative or post-traumatic complications impairing 
the healing processes of defective tissue. With 16 %, the post-operative wound infections are the third 
most common nosocomial infections associated with increased morbidity and mortality [6]. The inci-
dence of post-operative wound infections varies depending on the type of surgery. According to the 
German National Reference Centre for Surveillance of Nosocomial Infections, the incidence for post-
operative wound infections is 9 % for patients undergoing open colon surgery and 0.9 – 2 % for patients 
undergoing joint replacement [7]. 
In infected tissues, e.g. in post-operative or post-traumatic wound infections, resident or therapeutically 
applied MSC come into direct contact with bacteria and bacterial components.  Since MSC affect im-
mune response and inflammation [8], the interaction of bacterial antigens with MSC might influence 
the healing and regeneration processes. However, the influence of bacteria or their components on MSC 
is only incompletely characterized to date. To apply MSC in cell therapies and to improve the treatment 
efficiency of these cells it is necessary to understand how cellular behavior, processes and molecular 
mechanisms are affected in the presence of bacteria and their components. Therefore, the aim of this 
study was to investigate the influence of bacteria and their cell wall components lipopolysaccharide 
(LPS) and lipoteichoic acid (LTA) on cellular processes, e.g. proliferation, adipogenic and osteogenic 
differentiation and migration of MSC in vitro. Since LPS and LTA are recognized by toll-like receptors 
(TLRs), the activation of TLRs and following nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-B) pathway was analyzed. 
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2. Introduction 
2.1. Adipose-derived MSC 
MSC support the regeneration of defective tissue by multi-lineage differentiation [9,10] and possess 
immunomodulatory properties. These immunomodulatory properties are probably mediated by para-
crine factors, such as cytokines, growth factors and other signaling molecules secreted by the MSC 
[11,12]. MSC are found in various tissues and organs within the body, including bone marrow, adipose 
tissue, skeletal muscle, nerve tissue, blood, hair follicle, intestinal epithelium, cardiac tissue, synovial 
membranes, umbilical cord blood, and others [13,14].  
MSC from adipose tissue (adipose-derived MSC, adMSC) have gained high interest because they can 
be obtained by a minimally invasive method and in large quantities by liposuction of subcutaneous 
adipose tissue [15–19]. The stromal vascular fraction (SVF) as a component of the lipoaspirate is a rich 
source of adMSC. These cells show proliferation in vitro, are capable of self-renewal and can differen-
tiate into cells of mesenchymal origin, e.g.: adipocytes, chondrocytes, osteoblasts, and myocytes [20–
24]. As defined by the International Society for Cellular Therapy and the International Federation of 
Adipose Therapeutics and Sciences, stem cells in the SVF of adipose tissue are positive for the cluster 
of differentiation (CD) 34 and negative for CD31, CD45, and CD235a [25]. Thereby, CD34 has an 
important role for positive selection of stem cells out of the SVF. After plastic adherence, adMSC are 
positive for CD29, CD44, CD71, CD90, and CD105 and negative for CD31, CD34, and CD45. With 
these CD markers adMSC are similar to bone marrow-derived MSC (bmMSC), except of CD106 that 
is only expressed on adMSC [21]. Many studies underline the therapeutic potential of adMSC in the 
regeneration of defective or impaired tissues. So far adMSC have been used in clinical trials to treat 
calvarial defects [26], fistulas associated with Crohn’s disease [27], urinary incontinence [28], hepatic 
graft versus host disease [29] and to improve wound healing [30,31]. Furthermore, adMSC were exam-
ined in regard to peripheral nerve regeneration [32], the treatment of ischemia [33], skin regeneration 
[34], and many other applications [10]. Thus, adMSC are a promising cell type in regenerative medicine 
and for cell therapy. 
 
2.2. Bacteria and their typical cell wall components LPS and LTA 
Bacteria can be distinguished according to their cell wall architecture in Gram-negative bacteria, i.e. 
Escherichia coli (E. coli), or Gram-positive bacteria, i.e. Staphylococcus aureus (S. aureus) and Strep-
tococcus pyogenes (S. pyogenes). The characteristic cell wall component of Gram-negative bacteria is 
LPS and of Gram-positive bacteria it is LTA (Figure 1).  
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Figure 1: Scheme of the cell wall structure of Gram-negative (a) and Gram-positive bacteria (b). Adapted from: Brown 
et al., 2015 [35]. a: The cell wall of Gram-negative bacteria consists of a thin layer of peptidoglycan, which is located in the 
periplasmic space between the outer and inner lipid membrane. Typical for Gram-negative bacteria is LPS, as specific microbe-
associated molecular pattern on the outer membrane. b: The cell wall of Gram-positive bacteria consists of only a single lipid 
membrane surrounded by a thick layer of peptidoglycan, in which LTA is anchored. 
Based on the specific microbe-associated molecular pattern LPS and LTA bacteria are recognized by 
mammalian cells via the TLRs. LPS activates TLR4 while LTA activates TLR2 [36–39]. The contact 
between cells and bacteria via TLRs is essential to induce the innate immunity.  
TLR activation by LPS or LTA is followed by signal transduction, which leads to the recruitment of the 
receptor associated adaptor protein myeloid differentiation primary response protein 88 (MyD88) and 
active common upstream activators (IRAK/TRAF6 and TAK1) of NF-B [40–42] (Figure 2). Further-
more, a MyD88-independent signaling pathway after TLR4 activation is known (Figure 2). After the 
activation of the upstream activators the inhibitor of NF-B kinase (IKK) complex is phosphorylated 
and thereby activated. Consequently, the inhibitor of kappa B (IB) of the NF-B dimer is phosphory-
lated and ubiquitinated and due to this degraded by the proteasome. After the degradation of IB the 
free active NF-κB dimer translocates from the cytoplasm into the nucleus and induces the transcription 
of a wide variety of genes involved in, for example: inflammation and immune response, production of 
inflammatory cytokines, apoptosis, proliferation and osteogenic differentiation [43–45].  
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Figure 2: Downstream signaling cascade of TLR2 and 4. Adapted from: Valerio et al., 2012 [46]. TLR activation leads to 
the recruitment of adaptor protein MyD88 and active common upstream activators (IRAK/TRAF6 and TAK1) of NF-B. 
Furthermore, a MyD88-independent signaling pathway after TLR4 activation is known (red dotted line). Active NF-κB trans-
locates from cytoplasm into the nucleus and induces the transcription of messenger ribonucleic acid (mRNA) which will ulti-
mately lead for example to increased cytokine production. 
 
The activation of TLR4 by LPS additionally requires CD14 as a co-receptor. As reviewed by Guha et 
al., in human monocytes/macrophages LPS binds to the LPS binding protein, this complex is delivered 
to CD14 and then LPS is transferred to TLR4 [47]. Cells lacking CD14 on their membrane can only 
respond to LPS when soluble CD14 (sCD14) is provided [48–50]. 
TLRs are present on MSC and the set of TLRs varies depending on the source of the cells. For example, 
human bmMSC were shown to express mRNA of TLR1-6, 9 and 10, while human adMSC express 
mRNA of TLR1-10, except TLR 8 [51–53]. Consequently, with TLR2 and TLR4 adMSC possess the 
receptors for the detection of the Gram-negative cell wall component LPS and the Gram-positive cell 
wall component LTA [54,55]. 
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2.3. Exposure of adMSC with bacteria in vitro 
In co-cultures of bacteria and eukaryotic cells, fast-growing bacteria quickly consume the culture media 
nutrients and eventually eukaryotic cells inevitably suffer from starvation and unfavorable pH values. 
Therefore, long-term co-cultivation experiments with bacteria and eukaryotic cells entails some impon-
derability. To circumvent this, the in vitro experiments are often performed with heat-inactivated bac-
teria or basic bacterial components such as LPS or LTA. Therefore, in most of the following studies the 
adMSC were exposed to LPS and LTA and only some few analyses were done with heat-inactivated 
bacteria. 
 
2.4. TLR agonists and MSC proliferation 
It is worthwhile to investigate the effect of TLR agonists on the cell proliferation, because inflammation 
caused by bacteria may affect the behavior of MSC. Some studies showed the influence of TLR agonists 
on MSC proliferation. For example, murine bmMSC are protected by 1 g/ml LPS from H2O2/serum 
deprivation-induced apoptosis by increasing the proliferation. However, higher LPS concentrations (i.e. 
10 g/ml) led to decreased proliferation of murine bmMSC [56]. Such protective effect of LPS was not 
observed in MSC from TLR4-deficient mice, indicating that the TLR4 pathway contributes to the effects 
of LPS on survival of MSC. Another group showed that proliferation of bmMSC from mice is also 
promoted by the TLR2 ligand Pam3Cys, a synthetic triacylated lipopeptide. However, in other studies 
no significant effect of the TLR4 activator LPS and the TLR2 activators LTA and peptidoglycan on the 
proliferation of human adMSC and bmMSC could be observed [53,57,58]. Because of the heterogene-
ous literature results, we investigated the proliferation of adMSC after exposure to LPS or LTA. Fur-
thermore, we analyzed the effect of a TLR4 inhibitor on this process, to examine the signaling pathway. 
 
2.5. Adipogenic and osteogenic differentiation of MSC 
The process by which fibroblast-like preadipocytes differentiate into adipocytes is called adipogenesis 
and occurs in several stages. First, the proliferative preadipocytes become growth arrested due to contact 
inhibition. Next, the cells re-enter the cell cycle induced by hormonal stimulation and arrest proliferation 
again. Finally, a cascade of transcription factors result in the expression of adipocyte-specific genes, 
which leads to the terminal adipocyte differentiation. The key modulators during the adipogenic differ-
entiation are the peroxisome proliferator-activated receptor  (PPAR) and CCAATT/enhancer binding 
proteins. Although these factors act synergistically in vivo, they can independently induce adipocyte 
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differentiation in vitro [59,60]. To achieve adipogenic differentiation of MSC in vitro a combination of 
the substances 3-isobutyl-1-methylxanthine, dexamethasone, insulin, and indomethacin is usually ap-
plied  [21,61]. 3-isobutyl-1-methylxanthine is a cyclic adenosine monophosphate (cAMP) phos-
phodiesterase inhibitor, which is used to stimulate the cAMP-dependent protein kinase pathway, dexa-
methasone stimulates the glucocorticoid receptor pathway and insulin accelerates lipid accumulation 
[62]. Indomethacin functions as a ligand for the adipogenic transcription factor PPAR, which is a key 
modulator of the adipocyte differentiation [63]. 
Osteogenic differentiation is the process by which MSC differentiate into osteoblasts, which are the 
pivotal cells responsible for bone formation [64]. During this process, osteogenic transcription factors, 
i.e. runt-related transcription factor 2 (Runx2), osterix, alkaline phosphatase (ALP), -catenin, core 
binding factor-1 alpha, are activated within the MSC, followed by the activation of respective proteins 
and mineralization of the extracellular matrix of the cells [65–67]. To induce osteogenic differentiation 
of MSC in vitro substances like dexamethasone, ascorbic acid and -glycerophosphate are necessary. 
Dexamethasone is a chemically-synthesized glucocorticoid, which can be used as an inflammation in-
hibitor and was shown to induce the osteogenic differentiation of MSC in vitro [68]. Cheng et al. showed 
that dexamethasone influenced the expression of matrix proteins, i.e. ALP and osteocalcin, leading to a 
mineralization of the extracellular matrix [69]. Ascorbic acid is necessary to synthesize the collagen of 
the connective tissue, which is an essential component of the extracellular bone matrix [70]. -glycer-
ophosphate serves as a source of phosphate and induces the incorporation of minerals into the extracel-
lular matrix [71]. 
 
2.6. TLR agonists and differentiation of MSC 
The effect of TLR agonists on differentiation of MSC was investigated by different groups with incon-
sistent results. LPS was found to increase osteogenic differentiation of human adMSC and bmMSC, but 
no influence on adipogenic differentiation was observed [51,53,58]. In contrast, Liotta et al. showed that 
TLR activation by LPS in general had no effect on osteogenic or adipogenic differentiation of human 
bmMSC [52]. Sun et al. found peptidoglycan to increase osteogenic, but reduce adipogenic differentia-
tion of human adMSC [45]. Pevsner-Fischer et al. showed a reduced osteogenic and adipogenic differ-
entiation of mouse bmMSC by Pam3Cys[72]. The influence of LTA on differentiation was not analyzed 
so far. Due to different cell sources (bmMSC or adMSC) and species (human or mouse) the results differ 
between the studies. Here, we investigated the differentiation of human adMSC after exposure to LPS 
or LTA. Furthermore, we analyzed the effect of a TLR4 inhibitor on the osteogenic differentiation. 
Introduction 
 
 7 
2.7. Migration of MSC 
Beside proliferation and differentiation also the migration of resident or applied MSC might be of rele-
vance during regeneration. However, it is unknown to which extent the migration should take place to 
support the regeneration of defective tissue. So far, it has been shown in vitro that the migration rate of 
adMSC was increased by platelet-rich plasma [73], stromal cell-derived factor 1 (SDF-1) [74], periostin 
[75], platelet-derived growth factor [76] and several other chemokines and growth factors such as mon-
ocyte chemoattractant protein-1, basic fibroblast growth factor, insulin-like growth factor 1, tumor ne-
crosis factor  (TNFα) etc. [77]. Furthermore, in vivo studies have shown migration of MSC towards 
brain tumor-initiating cells [78] and enhanced MSC homing towards an injured heart by upregulation 
of SDF-1/C-X-C chemokine receptor type 4 [79]. Several groups investigated the migratory capacity of 
non-adipose MSC in response to bacterial components by scratch and transwell assays. Some of them 
described an increased migration of human bmMSC [80] and human dental pulp stem cells [81,82] upon 
LPS stimulation in vitro, whereas others observed a decreased [83] or unaffected migration of mouse 
bmMSC [84]. An increased migration of human dental pulp stem cells also was seen in response to an 
extract of Gram-positive bacteria [82]. However, Lei et al. showed a decreased migration of mouse 
bmMSC stimulated with the synthetic lipopeptide Pam3Cys [85]. Hence, the impact of bacterial com-
ponents seems to differ depending on the type of MSC and possibly also on the cultivation conditions. 
So far, the migration and chemotaxis of human adMSC in response to LPS and LTA have not been 
analyzed. Therefore, we investigated the migration rate and chemotaxis of adMSC in response to LPS 
or LTA by three different model systems: the transwell migration assay, the scratch assay and a specific 
chemotaxis assay. 
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3. Methods 
The following descriptions of the methods are presented in an abbreviated and summarized form. For 
detailed description of the methods see the material and methods part in the published articles. 
Isolation and cultivation of adMSC  
adMSC were isolated from adipose tissue, obtained by liposuction of healthy male and female individ-
uals. Donors gave a written informed consent and the study obtained approval from the ethics committee 
of the Rostock University Medical Center. Furthermore, the ethical standards defined by the World 
Medical Association Declaration of Helsinki were complied with. The liposuction tissue was digested 
by adding collagenase for 30 minutes, followed by filtration and washing steps. Afterwards, isolated 
stroma cells were cultured for 24 h in Dulbecco's Modified Eagle's-Medium (DMEM, high glucose; Life 
Technologies GmbH, Darmstadt, Germany) containing 10 % fetal calf serum (FCS) and 1 % penicil-
lin/streptomycin (Life Technologies GmbH) at 37 °C and 5 % CO2 in a humidified atmosphere. After 
removing non-adherent cells, the CD34-positive subpopulation was isolated using the Dynabeads
® 
CD34 positive isolation kit (Life Technologies) and seeded into culture flasks for cultivation. At this 
point cultured cells were termed as passage 1. adMSC were expanded in DMEM at 37 °C and 5 % CO2 
in a humidified atmosphere. Every 2–3 days the medium was changed and, at a confluence of 80–90 %, 
cells were subcultivated. For experiments, cells from passage 2–4 were placed into the respective assay. 
The presence of the MSC markers CD29, CD44, CD105, and CD166 as well as the absence of CD14+ 
/CD68+ as monocytes/macrophages markers, and CD31+ of endothelial cells was confirmed. Further-
more, the osteogenic and adipogenic differentiation potential of these adMSC was verified. 
Bacterial strains and culture conditions  
The E. coli strain used in this study has been freshly isolated at the Rostock University Medical Center 
from a patient with a wound infection. The S. aureus strain (spa type t331) derives from an endopros-
thetic hip infection. The S. pyogenes M14 strain JS95 is an isolate from a patient with necrotizing 
fasciitis and was kindly provided by Emanuel Hanski (Hebrew University, Jerusalem, Israel). E. coli 
standard cultivation was in lysogeny broth medium at 37 °C under constant shaking in ambient air con-
ditions. S. pyogenes was grown in Todd Hewitt broth medium supplemented with 0.5 % yeast extract 
under a 5 % CO2/20 % O2 atmosphere without shaking. S. aureus cultures were grown in Brain Heart 
Infusion medium at 37 °C under constant shaking in ambient air conditions. 
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Adherence and internalization of bacteria 
Adherence and internalization of E. coli, S. pyogenes and S. aureus strains to adMSC was determined 
by an antibiotic protection assay. Briefly, early stationary phase bacteria were suspended in DMEM 
(high glucose; Life Technologies GmbH, Darmstadt, Germany) containing 10 % FCS to an optical den-
sity (OD; at 600 nm) of 0.05. adMSC grown to sub-confluence in 24-well plates were infected with the 
bacterial suspension. After 2 h, the eukaryotic cells from three wells were lysed, and the number of 
bacteria contained in the lysate was assessed by viable counts. In another three wells the eukaryotic cells 
were exposed to culture medium containing penicillin (50 U/ml) and streptomycin (50 g/ml) for Gram-
positive bacteria and with ampicillin (100 g/ml) for E. coli for another 2 h. Then these cells were lysed 
and the bacteria were counted as above. As a control bacteria were incubated without eukaryotic cells. 
Viable counts determined from the lysed cells were related to the control. 
Heat inactivation of bacteria 
For heat inactivation, bacteria were grown overnight in the respective media, harvested by centrifuga-
tion, washed twice, suspended in DMEM to an OD of 0.5, and incubated for 30 min at 80 °C in a water 
bath. Subsequently, 100 ml of the suspension were plated on agar plates to make sure that no culturable 
bacteria remained. 
Quantification of cell amount  
The cell amount was quantified by crystal violet staining. Briefly, cells were fixed with 2-Propanol 
(SERVA Electrophoresis GmbH, Heidelberg, Germany), washed with PBS containing 0.05 % Tween 
20 (Sigma-Aldrich Chemie GmbH) and stained with 0.1 % crystal violet (Sigma-Aldrich Chemie 
GmbH). DNA-bound crystal violet was extracted by shaking with 33 % acetic acid (Merck KGaA, 
Darmstadt, Germany). The absorbance of the supernatants was measured at 600 nm using a microplate 
reader (anthos Mikrosysteme GmbH, Krefeld, Germany). 
Quantification of metabolic activity 
Cellular metabolic activity was quantified in a tetrazolium dye conversion assay using the CellTiter 96 
AQueous One Solution Cell Proliferation Assay (MTS; PROMEGA GmbH, Mannheim, Germany). 
Briefly, cells were incubated in culture medium containing 20 % MTS for 60 min at 37 °C and 5 % CO2 
in a humidified atmosphere. The absorbance of the supernatants was measured at 600 nm using a mi-
croplate reader (anthos Mikrosysteme GmbH, Krefeld, Germany). 
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Quantification of lipid amount  
Cells were fixed with 4 % paraformaldehyde (PFA) and Bodipy solution (1 mg/ml in 150 mM NaCl; 
Fisher Scientific, Schwerte, Germany) was added and incubated for 10 min at room temperature in the 
dark. The fluorescence intensity of cell lipid-bound Bodipy dye was quantified at 515 nm using a mi-
croplate reader (TECAN, Crailsheim, Germany).  
Analysis of osteogenic differentiation  
Osteogenic differentiation was detected on two levels: the enzyme activity of the ALP and the calcium 
deposition in the extracellular matrix. For quantification of ALP activity, washed cells were lysed and 
incubated in a substrate buffer (10 mM para- nitrophenyl phosphate, 100 mM 2-Amino-2-methyl-1,3-
propanediol, 5 mM MgCl2 (all substances AppliChem GmbH) in ultrapure water). The absorbance of 
supernatants was measured at 405 nm using a microplate reader (anthos Mikrosysteme GmbH). For 
Quantification of calcium in the extracellular matrix, fixed cells were incubated with a cresolphthalein 
solution (0.0025 % o-cresolphthalein complexon (Sigma-Aldrich Chemie GmbH), 0.025 % 8-Quino-
linol (Sigma-Aldrich Chemie GmbH), 6 % of 37 % hydrochloric acid (Merck, Darmstadt, Germany) in 
ultrapure water). After the addition of ultrapure water containing 15 % 2-Amino-2-methyl-1-propanol 
(Sigma-Aldrich, Chemie GmbH) with a pH of 10.7, the absorbance of the supernatants was measured 
at 580 nm using a microplate reader (anthos Mikrosysteme GmbH).  
Scanning electron microscopy  
For scanning electron microscopy, adMSC were cultivated on cover slips. Samples were fixed with 
2.5 % glutardialdehyde, washed with sodium phosphate buffer (0.1 M, pH 7.3), and dehydrated in a 
graded series of ethanol. Subsequently, cover slips were subjected to critical point drying with CO2, 
covered with gold to a 10 nm layer, and examined with a Zeiss DSM 960 A electron microscope. 
Quantitative real-time PCR  
For quantitative real-time reverse transcription PCR (qPCR), adMSC were homogenized by centrifuga-
tion for 1 min at 14,000 rounds per minute and 4 °C on QIAshredder columns (Qiagen, Hilden, Ger-
many). Subsequently, RNA was isolated using the innuPREP RNA Mini Kit (Analytik Jena, Jena, Ger-
many) following the manufacturer′s instructions. RNA was transcribed into cDNA using the QuantiTect 
Reverse Transcription Kit (Qiagen). qPCR was performed in a 7500 Real Time PCR system using the 
Power SYBR Green PCR Master Mix (Life Technologies GmbH, Darmstadt, Germany) and primers for 
targeting genes of alkaline phosphatase (liver/bone/kidney) and zinc finger and BTB domain containing 
protein 16. Gene expression levels were determined using the ΔΔCT method with normalization to hu-
man-specific β-actin. 
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Flow cytometry  
TLR4 and CD14 on the cell surface of adMSC were analyzed by flow cytometry. For this purpose, 
trypsinized cells were incubated with fluorescence-labeled antibodies against CD14 or TLR4. The fol-
lowing antibodies were used: Allophycocyanin-labeled anti-human CD284 (TLR4) and phycoerythrin 
(PE)-labeled anti-human CD14 purchased from eBiosciences (Frankfurt am Main, Germany). For iso-
type control PE-labeled mouse immunoglobulin (IgG) 1 or IgG2a antibodies were used (Acris Antibod-
ies, Herford, Germany). Cells were analyzed with a BD FACSCaliburTM (BD Biosciences, Heidelberg, 
Germany). For the interpretation and analysis of the results, FlowJo software (version 10.0.6, FlowJo 
LLC, Ashland, USA) was used. 
Visualization and quantification of NF-κB p65 translocation  
Activation of the NF-κB signal transduction was analyzed by visualizing and quantifying the extent of 
the NF-κB subunit p65 translocation into the nucleus as revealed by immunofluorescence staining. For 
this purpose, fixed cells were labeled with an NF-κB-p65 specific monoclonal rabbit antibody and 
Lamin A/C mouse antibody (Cell Signaling Technologies, Danvers, MA, USA). Then the cells were 
stained with Alexa Fluor 488 goat anti mouse IgG and Alexa Fluor 555 goat anti rabbit IgG secondary 
antibodies (Invitrogen, Darmstadt, Germany). Cells were imaged with the fluorescence microscope Ob-
server Z1 (Zeiss, Jena, Germany). For quantification of fluorescence intensities of the fluorescence-
labeled NF-κB-p65 in the nucleus of the adMSC the Hermes WiScan system (IDEA Bio-Medical, Re-
hovot, Isreal) was used. 
ELISA  
The interleukin (IL) 6 and 8 amount of the cell culture medium was determined by DuoSet
 
ELISA 
Development Kit human IL-6 and CXCL8/IL-8 (R&D Systems, Minneapolis, MN, USA), respectively, 
according to the manufacturer's protocol. In brief, Nunc MaxiSorp 96-well plates were coated over-
night with capture antibody. The plates were then blocked, manufacturer's standards as well as the sam-
ples were added to the plates and incubated with detection antibody. At the end, plates were incubated 
with streptavidin-horseradish peroxidase and substrate solution. The OD was measured at 450 nm with 
a microplate reader (Anthos Mikrosysteme GmbH, Krefeld, Germany). 
Transwell migration assay  
For transwell migration assays, cell culture inserts (BioCoat, 8 mm pores; BD, Heidelberg, Germany) 
in a 24-well plate (Greiner Bio-One) were used. Cells were seeded onto the membrane in the upper 
chamber. The lower chamber was filled with cell culture medium containing the chemoattractant. After 
48 h at 37 °C and 5 % CO2 in a humidified atmosphere, non-migrated cells on the upper side of the 
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membrane were removed. The number of migrated adMSC on the lower side of the membrane was 
determined via Cell Titer 96
 
AQueous One Solution Cell Proliferation Assay (MTS; Promega GmbH, 
Mannheim, Germany). The absorbance was measured at 490 nm in a microplate reader (anthos 
Mikrosysteme GmbH, Krefeld, Germany).  
Scratch assay  
For the scratch assays, specific culture inserts with a defined cell-free gap (Ibidi GmbH, München, Ger-
many) were used in a 24-well plate. Cells were seeded into the insert and incubated for 48 h at 37 °C 
and 5 % CO2 in a humidified atmosphere. Removing the inserts resulted in a regular gap of 500 m 
width within a confluent cell monolayer. Cells were then cultured with medium containing the chemo-
attractant for 24 h. For staining the nuclei, the cells were fixed with 4 % PFA (Sigma-Aldrich) and 
embedded into Fluoroshield with DAPI (ImmunoBioScience Corp., Mukilteo, WA, USA), which 
stained the nuclei. Fluorescence microscopy (Axio Observer.Z1, Carl Zeiss, Jena, Germany) was used 
to image nuclei of 3 selected fields of every scratch. Images were imported to ImageJ (version 1.47, 
open source by National Institute of Health, USA) to determine total cell number and number of cells 
within the gap by counting nuclei. 
Chemotaxis  
For chemotaxis experiments, a linear and stable chemoattractant-gradient was generated by the applica-
tion of the -Slide Chemotaxis3D chamber (Ibidi GmbH). Cells within the chemotaxis chamber were 
analyzed over 12 h by time-lapse microscopy at 37 °C and 5 % CO2 in a humidified atmosphere (LSM 
780, Carl Zeiss). The resulting microscopic images were imported into ImageJ software (version 1.47, 
Plugin manual tracking, open source by National Institute of Health, USA) to track randomly chosen 
cells. Data of the tracked cells were transferred to chemotaxis and migration toll software (version 2.0, 
Ibidi) to create trajectory plots of cell migration and to calculate the chemotactic parameters: center of 
mass, forward migration indices parallel and perpendicular, p-value of the Rayleigh test and velocity.  
Data illustration and statistical analysis  
All experiments were performed independently with cells from three or more donors, each in triplicate. 
Data visualization and statistical calculations were performed using GraphPad Prism (version 6.05, 
Graphpad Software Inc., USA). Data were displayed as boxplots with whiskers from the minimum to 
the maximum data point or as dot plots, where the median was plotted as a horizontal line. Significance 
was fixed at p < 0.05 and tested using an unpaired t-test.  
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4. Results 
 
4.1. Study I 
 
Impact of bacteria and bacterial components on osteogenic and adipogenic differentiation of adi-
pose-derived mesenchymal stem cells 
Tomas Fiedler, Achim Salamon, Stefanie Adam, Nicole Herzmann, Jan Taubenheim, Kirsten Peters 
Exp. Cell Res. 319 (2013) 2883–2892 
 
Summary 
Invasive bacterial infections are common complications in wound healing. Within that milieu MSC 
could get into contact with bacteria, but not much is known about the impact of bacteria and their com-
ponents on viability and differentiation of MSC. In this study, we investigated the influence of Gram-
negative and Gram-positive wound infection relevant bacteria, E. coli, S. aureus, and S. pyogenes, and 
the typical cell wall components LPS and LTA on adMSC viability, proliferation, and osteogenic as 
well as adipogenic differentiation. We showed that the tested bacteria attached to and internalized into 
adMSC. Furthermore, heat-inactivated Gram-negative bacteria and its cell wall component LPS induced 
proliferation and osteogenic differentiation of adMSC, whereas adipogenic differentiation was reduced. 
Gram-positive bacteria showed same effects on proliferation and adipogenic differentiation, but no sig-
nificant reaction of adMSC was shown after LTA exposure. Therefore, the data show that bacterial 
antigens have an impact on proliferation and differentiation of adMSC, which might be of relevance 
during regeneration of defective tissue. 
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4.2. Study II 
 
Lipopolysaccharide induces proliferation and osteogenic differentiation of adipose-derived mes-
enchymal stromal cells in vitro via TLR4 activation 
N. Herzmann, A. Salamon, T. Fiedler, K. Peters 
Exp. Cell Res. 350 (2017) 115–122 
 
Summary 
We showed already an increased proliferation and osteogenic differentiation of adMSC after exposure 
to purified LPS from the Gram-negative bacterium E. coli. In this study, we elucidate the underlying 
mechanisms. We found that adMSC expressed TLR4 at the surface and that osteogenic differentiation 
increases the amount of this receptor. Furthermore, the NF-κB signaling pathway is activated upon 
LPS/TLR4 interaction and the LPS-induced increase in proliferation and osteogenic differentiation of 
adMSC could be abolished by competitive inhibition of TLR4. These results indicate that the LPS/TLR4 
interaction is causative for the observed effects. Noticeably, the inhibition of TLR4 leads to the complete 
absence of osteogenic differentiation even when osteogenically stimulated. Thus, it is tempting to spec-
ulate that effects of bacterial cell wall components on proliferation and differentiation of adMSC are 
also mediated through TLR4. 
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4.3. Study III 
 
Analysis of migration rate and chemotaxis of human adipose-derived mesenchymal stem cells in 
response to LPS and LTA in vitro 
N. Herzmann, A. Salamon, T. Fiedler, K. Peters 
Exp. Cell Res. 342 (2016) 95–103 
 
Summary 
Beside proliferation and differentiation also migration of MSC might be of relevance during regenera-
tion of infected tissue. Since adMSC are able to respond to LPS and LTA, we were interested in whether 
their migratory activity would also be affected by these bacterial cell wall components. Therefore, in 
this study we investigated the influence of bacterial cell wall components LPS and LTA on the chemo-
taxis and migration rate of adMSC. We used transwell and scratch assays, as well as a specific new 
chemotaxis assay combined with live-cell imaging. All different assays led to the same result: No sig-
nificant influence of LPS or LTA was found on the migration rate of adMSC and no chemotactic effect 
could be observed. 
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5. Discussion 
 
The therapeutic application of MSC has a promising perspective in regenerative medicine. MSC have 
already been used to treat defects in individual cases as well as in different clinical studies [28,29,86–
89]. Since bacterial infections are a typical complication in wound healing, resident or applied MSC 
could come into direct contact with bacteria or their components. The response of MSC towards patho-
gens could influence their regeneration potential. Thus, in the first study, we analyzed the proliferation, 
and adipogenic as well as osteogenic differentiation of adMSC in response to Gram-positive and -neg-
ative bacteria and their typical cell wall components LPS and LTA. Since we could show that adMSC 
react to LPS by increased proliferation and osteogenic differentiation, we analyzed the impact of the 
LPS/TLR4 interaction on the proliferation and differentiation of adMSC in the second study. Beside 
proliferation and differentiation, the migration capacity of MSC towards affected tissue might also be 
influenced by bacterial components. Thus, we analyzed the impact of LPS and LTA on the migratory 
activity of adMSC in the third study. 
 
5.1. TLRs on MSC 
Bacteria and their components are recognized by TLRs followed by signal transduction, which leads to 
an immune response in most mammalian cells, including MSC [51,52,90]. The set of TLRs present on 
the surface of MSC varies depending on the source of the cells. For example, human bmMSC were 
shown to express mRNA of TLR1-6, 9 and 10, while human adMSC express mRNA of TLR1-10, except 
TLR 8 [51–53]. Consequently, adMSC have the ability to detect the Gram-negative cell wall component 
LPS via TLR4 and the Gram-positive cell wall component LTA via TLR2, leading to cellular reactions 
[54,55]. The interaction of TLR4 with LPS additionally requires CD14 as a co-receptor [47–50]. 
In our studies, we could confirm that TLR4 is present on the surface of adMSC. Furthermore, our data 
show that osteogenic stimulation of adMSC with the dexamethasone/ascorbic acid/β-glycerol phosphate 
mixture enhanced the protein amount of TLR4 significantly. This supports the results of Mo et al., who 
found an increased TLR4 gene expression in bmMSC after 12 days of osteogenic differentiation by 
using a similar stimulation mixture [58]. The same group also observed a decreased TLR4 gene expres-
sion in bmMSC after 12 days of exposure to LPS. However, we found that treatment with LPS did not 
affect the protein amount of TLR4 on adMSC cultured in either unstimulating or osteogenically stimu-
lating media. Therefore, our data rather confirm a previous report of Lombardo and colleagues, who 
also found no significant effect of LPS on the TLR4 amount of unstimulated human adMSC [53]. These 
contradictory results could indicate a biological difference in the response of MSC from bone marrow 
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and from adipose tissue to the LPS stimulus. Different experimental approaches also may cause these 
differences, since Mo and colleagues measured TLR4 expression on the RNA level, whereas in our 
study and in the study done by Lombardo et al., the TLR4 protein amount was determined. 
We found no CD14, an important co-receptor of TLR4, on adMSC under unstimulating conditions. This 
is in line with several other studies, where adMSC were also described to be CD14 negative [21,91–93]. 
The cultivation of adMSC under osteogenic differentiation conditions led to a very slight increase in the 
fluorescence intensities of stained cells compared to isotype controls, indicating that very low amounts 
of CD14 may be present on adMSC under these conditions. The exposure to LPS did not change the 
CD14 amount on adMSC under either condition. To our knowledge, the influence of LPS or osteogenic 
differentiation on the amount of CD14 on cells has not been investigated before. 
 
5.2. TLR activation and signal transduction 
Stimulation of TLR4 with LPS usually leads to the activation of the NF-κB signaling pathway [40]. 
Consequently, we observed a significant NF-κB-p65 translocation into the nucleus upon LPS treatment. 
In our experimental setting, the LPS dependent NF-κB activation depends on either the presence of 
serum or sCD14 supplementation. It has previously been shown that CD14 negative cells can be acti-
vated by LPS only when sCD14 is supplied [47,50]. Thus, sCD14 seems to be necessary to activate NF-
κB signaling in adMSC upon LPS exposure. We assume that the serum used in our study also contains 
sCD14 to some extent, since in the presence of serum no additional sCD14 was required to induce NF-
κB signaling upon LPS exposure. Furthermore, in the absence of serum, the addition of sCD14 was 
sufficient for the LPS-induced activation of the NF-κB signaling pathway. 
 
5.3. Effect of bacteria and their components on proliferation of MSC 
An impact of heat-inactivated bacteria on MSC has not been investigated so far. We observed an in-
creased proliferation of adMSC in the presence of the heat-inactivated Gram-negative bacterium E. coli 
and Gram-positive bacteria S. pyogenes and S. aureus. The cell wall component LTA did not affect the 
proliferation of the cells, whereas we showed an increased proliferation of adMSC upon LPS treatment 
after 14, 21 and 28 days. In contrast to the work of Cho et al., who showed an unaffected proliferation 
after 48 h of LPS exposure [57], we observed an increased adMSC proliferation after long-term expo-
sure. Also for murine bmMSC and MSC derived from human turbinate tissue an increased proliferation 
after treatment with LPS was described [56,94,95].  
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In osteogenically stimulated cultures maintained longer than 2 weeks, the proliferation activity of ad-
MSC upon LPS exposure appears very high. This leads to detached spheroid-like cell aggregates, getting 
lost during the exchange of cell culture medium. Thus, lower relative values on average and high vari-
ations of the cell amounts after osteogenic differentiation in the presence of LPS were measured on days 
21 and 28. The higher responsiveness to LPS in osteogenically stimulated cells in terms of proliferation 
could be due to the increase in TLR4 levels upon osteogenic stimulation.  An increased proliferation of 
MSC may occur to counteract the degenerative processes within a bacterial infected tissue, which re-
mains to be elucidated. 
 
5.4. Effect of TLR4 inhibition on proliferation of MSC 
It has been reported by us and others that the treatment of MSC with LPS leads to increased cell prolif-
eration [96–98]. Furthermore, we could show that the competitive inhibition of TLR4 completely abol-
ished the LPS-induced increase in proliferation of adMSC. To our knowledge, the effects of the inhibi-
tion of TLR4 on the proliferative activity have not been investigated for MSC before. However, in nor-
mal skin fibroblasts, the inhibition of TLR4 led to a notably reduced LPS-mediated proliferation [99]. 
Since LPS-induced NF-κB-p65 translocation into the nucleus could completely be abolished when ad-
MSC were treated with either a neutralizing anti-TLR4 antibody or the competitive TLR4 inhibitor, our 
data support the conclusion that TLR4 is involved in the regulation of proliferation. 
 
5.5. Effect of bacteria and their components on differentiation of MSC 
We could show that the osteogenic differentiation of adMSC was enhanced by heat-inactivated Gram-
negative E. coli as well as by its cell wall component LPS. In contrast, no significant effect of heat-
inactivated Gram-positive species S. aureus and S. pyogenes and their cell wall component LTA on 
osteogenic differentiation was observed. An increased osteogenic differentiation of adMSC is indicated 
by the induction of osteogenic markers like the expression of osteogenic transcription factors, the activ-
ity and expression of ALP and the calcification of the extracellular matrix [100–102]. Despite the cell 
culture model-immanent loss of cells during the treatment with LPS, osteogenic differentiation markers 
could still be determined, because remaining cells proliferated fast over the experimentation period. LPS 
treatment on average increased osteogenic differentiation of adMSC compared to control cells cultivated 
without LPS. This is in line with published data showing an increased osteogenic differentiation of 
adMSC after LPS exposure, while no impact of LTA was described [53,57,58]. Thus, we and others 
could show an osteoinductive effect of E. coli and LPS on MSC.  
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The adipogenic differentiation of adMSC was decreased upon exposure to heat-inactivated Gram-posi-
tive and Gram-negative bacteria and the cell wall component LPS, but not by LTA. Others showed an 
unaffected adipogenic differentiation after LPS treatment [53,57], but no data indicate a supportive im-
pact on adipogenic differentiation of MSC. There is evidence in the literature that osteogenic and adi-
pogenic differentiation seem to be inversely coupled processes. Maroni and colleagues showed that the 
osteogenic marker Runx2 and the adipogenic marker PPAR were oppositely affected after histone 
deacetylases inhibition, which led to the engagement of adMSC towards bone lineage [103]. Further-
more, Byun and colleagues mentioned that transcriptional coactivator with PDZ-binding motif stimu-
lates the activity of Runx2 to modulate osteoblastic differentiation and suppresses the activity of PPAR 
simultaneously [104]. Additionally, Kim and colleagues described a shift of the differentiation potential 
from osteogenic to adipogenic in ageing MSC [105]. Consequently, an inverse effect on adipogenic 
differentiation is possible because adMSC showed a great potential to differentiate into osteogenic lin-
eage after LPS exposure. 
 
5.6. Effect of TLR4 inhibition on osteogenic differentiation of MSC 
We showed that the LPS-induced increased osteogenic differentiation of adMSC was completely abol-
ished by competitive inhibition of TLR4. During the osteogenic differentiation of adMSC an inhibition 
of TLR4 led to a pronounced reduction in extracellular matrix mineralization. The data support the 
conclusion that TLR4 is involved in the regulation of osteogenic differentiation. Cho et al. showed an 
increased gene expression of osteogenic marker genes, e.g. those encoding for Runx2, osteopontin and 
ALP in adipose-derived stromal cells exposed to TNF and LPS [106]. Furthermore, this group showed 
that the expression of the osteogenic marker genes could be blocked by NF-κB inhibition. Since in our 
experiments blocking of TLR4 with either a neutralizing antibody or a competitive inhibitor interrupts 
the LPS-induced NF-κB activation, LPS seems to increase osteogenic differentiation through TLR4 and 
subsequent NF-κB activation. As shown by Hess at al. and Feng et al., NF-κB signaling triggered also 
an increased osteogenic differentiation of human bmMSC and human dental pulp stem cells stimulated 
by TNF [43,44]. Hence, the activation of the NF-κB signaling pathway plays a role in the osteogenic 
differentiation of MSC. The link between the activation of TLR4 and osteogenic differentiation is al-
ready shown [107,108]. In our study, we could show that the calcification of the extracellular matrix 
was completely abolished after the inhibition of TLR4, even when cells were osteogenically stimulated. 
Wang et al. found that in TLR4 knockout mice the healing effect of bone graft was inhibited without 
TLR4 signaling [109]. These observations and our findings indicate an as yet unknown role of TLR4 in 
osteogenic differentiation and bone formation. 
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5.7. Effect of LPS and LTA on migration of MSC 
Depending on the origin of MSC and the test system, different results regarding the migratory activity 
of these cells were reported. The migration of mouse bmMSC was unaffected by LPS exposure [84], 
whereas the migration of human bmMSC [80] or dental pulp stem cells [81,82] was increased by LPS 
(tested in transwell assays). We observed a tendency of increased adMSC migration in the transwell 
assay which was LPS concentration-dependent. Contrariwise, the adMSC cultured in the scratch assay 
were not affected by LPS exposure. In the μ-slide chemotaxis assay the stimulation with LPS did not 
exert any chemotactic effect on adMSC as well. Tomchuck et al. demonstrated an LPS-induced release 
of chemokines and growth factors (RANTES, Chemokine (C-X-C motif) ligand (CXCL) 10 and TNFα) 
by MSC [80]. Baek et al. showed an increased migration of human adMSC in response to different 
chemokines and growth factors, e.g. RANTES and TNFα [77]. Thus, a detected increased migration of 
cells may result from an indirect and delayed effect of the chemokines and growth factors released by 
MSC. This may explain why we observed a slight LPS concentration-dependent increase in migration 
rates in the transwell assay taking 48 h to complete, while all shorter assays did not reveal obvious 
effects on adMSC migration (scratch: 24 h, chemotaxis assay: 12 h). Moreover, in a transwell assay 
cells could migrate through a membrane from an upper into a lower chamber. The migration of cells 
was determined by the amount of cells on the backside of the membrane in the lower chamber. It was 
not possible to control whether all of these cells are migrated to the lower chamber. It may be possible 
that only few cells were migrated. Since we showed an increased adMSC proliferation induced by LPS, 
these few cells may have proliferated in the presence of LPS. Thus, a detected increased migration 
within the lower chamber of the transwell assay might be the result of few cells that undergo prolifera-
tion triggered by LPS. As well, divergent results of the different research groups could be explained by 
the various experimental procedures used to analyze MSC migration. Zeuner et al. suppose that experi-
mental outcomes are dependent on  the bacterial source of LPS, the purity of the LPS, the concentration, 
the incubation time and other parameters [98]. A further crucial aspect is the identity of the used cell 
population. In most studies, the MSC population was not purified according to stem cell surface markers, 
but only for adherence to cell culture plastic. In our experiments, the adMSC population was selected 
by CD34-positivity and plastic adherence. 
No changes of the adMSC migratory activity was observed upon LTA stimulation within transwell or 
scratch assays in our experiments. To our knowledge, the effects of LTA on the migration of stem cells 
have not been investigated yet. Chmilewsky et al. showed that human pulp progenitor cells were at-
tracted by C5a (component of the complement system of the immune system) generated by pulp fibro-
blasts after LTA stimulation [110]. Durand et al. showed that the migration of dendritic cells was aug-
mented by an increased amount of Chemokine (C-C motif) ligand 2 and CXCL10 in the supernatant 
secreted by in vitro differentiated and LTA stimulated odontoblasts [111]. Thus, LTA was not directly 
responsible for cell migration, but rather had an indirect effect through stimulation of the secretion of 
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substances affecting the migratory activity. A decreased migration of mouse bmMSC after stimulation 
with Pam3Cys was shown by Lei et al. [85]. Although Pam3Cys is recognized by the same receptor as 
LTA, we could not show any effect on the migratory activity of adMSC in response to LTA. However, 
the biological activity of LTA may vary and it could not be excluded that other concentrations of the 
substance would be more effective. 
In summary, our results indicate that LPS or LTA do not directly affect migration and chemotaxis of 
adMSC in vitro. However, although in vitro models are applicable to the analysis of specific reactions 
of cells in response to single stimuli, they might not reflect the cellular behavior in vivo. Thus, further 
investigations are necessary to elucidate the role of bacterial pathogens as effectors on MSC migration. 
 
5.8. Immunmodulatory properties of MSC 
In addition to their differentiation potential, MSC have been proposed to have immunomodulatory prop-
erties [112,113]. We and others could show that the exposure of adMSC to LPS leads to the release of 
pro-inflammatory cytokines IL-6 and IL-8 [114,115]. Thus, a pro-inflammatory activation of MSC by 
LPS via NF-κB is proven. On the other hand, numerous studies have shown an anti-inflammatory po-
tential of the MSC that is characterized by the inhibition of the proliferation of T lymphocytes and 
natural killer cells, suppression of immunoglobulin production by plasma cells, inhibition of the matu-
ration of dendritic cells, stimulation of the proliferation of regulatory T cells and stimulation of anti-
inflammatory IL-10 production of monocytes and T cells [116–118]. Furthermore, application of MSC-
derived molecules led to the inhibition of inflammatory responses, reduction of apoptosis, prevention of 
fibrosis, stimulation of endogenous regenerative programs and neovascularization in acute liver injury 
in vivo [119]. Thus, MSC possess immunomodulatory properties which are probably mediated by para-
crine factors, such as cytokines, growth factors and other signaling molecules secreted by the MSC 
[11,12]. 
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6. Summary 
MSC are known for their self-renewal, multilineage differentiation potential and their regenerative po-
tential, which was shown in various studies and several clinical trials. Therefore, MSC are a promising 
tool for cell therapies in regenerative medicine. Wound infections due to bacteria are common post-
operative or post-traumatic complications impairing the healing processes of defective tissue. MSC re-
cruitment and differentiation play important roles in the regeneration of these wounds. Since MSC get 
into contact with bacteria and their components within the infected tissue, the interaction of bacterial 
antigens with MSC might have an overall influence on healing and regeneration processes. However, 
the influence of bacteria or their components on MSC is only incompletely characterized to date. There-
fore, the aim of the studies was to analyze the influence of Gram-negative and Gram-positive wound 
infection relevant bacteria, E. coli, S. aureus, and S. pyogenes, and their typical cell wall components 
LPS and LTA on different cellular processes. 
In the present studies, we could show that heat-inactivated Gram-negative bacteria and their cell wall 
component LPS induced proliferation and osteogenic differentiation of adMSC, whereas adipogenic 
differentiation was reduced. Heat-inactivated Gram-positive bacteria increased the proliferation and re-
duced the osteogenic and adipogenic differentiation, but no significant reactions were shown after LTA 
exposure. Furthermore, we found that adMSC possess TLR4, which is relevant for recognizing LPS and 
that osteogenic differentiation increased the amount of this receptor. The NF-κB signaling pathway was 
activated upon LPS stimulation and the LPS-induced increase in proliferation and osteogenic differen-
tiation of adMSC could be abolished by competitive inhibition of TLR4. These results indicate that the 
LPS/TLR4 interaction is causative for the observed effects. Thus, it is tempting to speculate that effects 
of bacterial cell wall components on proliferation and differentiation of adMSC are mediated through 
TLR4. The migration of adMSC, which might be of relevance during regeneration of infected tissue, 
was not significantly influenced by LPS or LTA. The data strengthen the evidence for a role of TLR4 
in the regulation of proliferation and differentiation of adMSC. This mesenchymal response to bacterial 
TLR ligands could also be involved in inappropriate tissue repair that might lead, for example, to ossi-
fication of soft tissue and fibrosis. Thus, it is necessary to extend the understanding of the molecular 
mechanisms and consequences of the interactions of MSC with bacteria or their components. 
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7. Zusammenfassung 
MSC sind in der Lage sich selbst zu erneuern und haben das Potential sich in verschiedene Zelllinien 
zu differenzieren. Das Regenerationspotential dieser Zellen wurde in diversen Untersuchungen und 
mehreren klinische Studien gezeigt. Demzufolge stellen MSC ein vielversprechendes Mittel zur Zell-
therapie in der regenerativen Medizin dar. Durch Bakterien hervorgerufene Wundinfektionen sind häu-
fige post-operative oder post-traumatische Komplikationen, welche den Heilungsprozess des defekten 
Gewebes beeinträchtigen. Für die Regeneration dieser Wunden spielen die Rekrutierung und Differen-
zierung der MSC eine wichtige Rolle. Da die MSC innerhalb des infizierten Gewebes mit Bakterien und 
ihren Bestandteilen in Kontakt kommen, könnte diese Interaktion zwischen bakteriellen Antigenen und 
den MSC einen generellen Einfluss auf die Heilung und den Regenerationsprozess haben. Allerdings ist 
der Einfluss der Bakterien und ihrer Bestandteile auf die MSC bisher nur unvollständig charakterisiert. 
Demzufolge war das Ziel dieser Studien den Einfluss der Wundinfektions-relevanten Gram-negativen 
und Gram-positiven Bakterien, E. coli, S. aureus und S. pyogenes und ihrer typischen Zellwandbestand-
teile LPS und LTA auf verschiedene zelluläre Prozesse zu analysieren.  
In den vorliegenden Studien konnte gezeigt werden, dass sowohl hitze-inaktivierte Gram-negative Bak-
terien als auch deren Zellwandkomponente LPS die Proliferation und osteogene Differenzierung der 
adMSC induzierten. Die adipogene Differenzierung war hingegen reduziert. Hitze-inaktivierte Gram-
positive Bakterien steigerten die Proliferation und reduzierten die osteogene und adipogene Differen-
zierung der adMSC. Die Exposition mit LTA löste keine signifikanten Reaktionen aus. Weiterhin konnte 
gezeigt werden, dass die adMSC TLR4 auf der Oberfläche besitzen, welcher relevant für die Erkennung 
von LPS ist. Die Menge an TLR4 erhöhte sich zusätzlich durch osteogene Stimulation. Der NF-κB-
Signalweg konnte durch LPS-Stimulation aktiviert werden und die LPS-induzierte erhöhte Proliferation 
und osteogene Differenzierung der adMSC konnte durch kompetitive Inhibition des TLR4 aufgehoben 
werden. Diese Ergebnisse zeigen, dass eine LPS/TLR4 Interaktion ursächlich für die beobachteten Ef-
fekte ist. Demnach könnte es sein, dass die Effekte der bakteriellen Zellwandbestandteile auf die Prolife-
ration und Differenzierung der adMSC durch den TLR4 vermittelt werden. Die Migration der adMSC, 
welche für die Regeneration eines infizierten Gewebes von Bedeutung sein könnte, wurde durch LPS 
und LTA nicht signifikant beeinflusst. Die Daten legen nahe, dass der TLR4 in die Regulation der 
Proliferation und Differenzierung der adMSC involviert ist. Die Reaktion der Zellen auf die bakteriellen 
TLR Liganden könnte auch bei einer inadäquaten Geweberegeneration eine Rolle spielen, zum Beispiel 
bei der Ossifikation von Weichgewebe oder fibrotischen Prozessen. Deshalb ist es notwendig das Ver-
ständnis über molekulare Mechanismen und Konsequenzen der Interaktion zwischen MSC und Bakte-
rien, sowie deren Bestandteilen, auszubauen. 
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9. Abbreviations 
 
adMSC  Adipose-derived mesenchymal stem cells 
ALP  Alkaline phosphatase 
bmMSC Bone marrow-derived mesenchymal stem cells 
cAMP  Cyclic adenosine monophosphate 
CXCL  Chemokine (C-X-C motif) ligand 
CD  Cluster of differentiation 
CO2  Carbon dioxide 
ΔΔCT  delta delta CT (threshold cycle) 
DMEM  Dulbecco's Modified Eagle's-Medium 
E. coli  Escherichia coli 
FCS  fetal calf serum 
IgG  Immunoglobulin 
IB  Inhibitor of kappa B 
IKK  Inhibitor of NF-B kinase 
IL  Interleukin 
IRAK  Interleukin-1 receptor-associated kinase 1 
LPS  Lipopolysaccharide 
LTA  Lipoteichoic acid 
mRNA  Messenger ribonucleic acid 
MSC  Mesenchymal stem cells 
MyD88  Myeloid differentation primary response protein 88 
NF-B  Nuclear factor kappa-light-chain-enhancer of activated B cells 
O2  Dioxygen 
OD  optical density 
Abbreviations 
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Pam3Cys Pam3Cys-Ser-(Lys)4, synthetic triacylated lipopeptide 
PFA  Paraformaldehyde 
PPAR  Peroxisome proliferator-activated receptor  
qPCR  quantitative polymerase chain reaction 
RANTES Regulated on activation, normal T cell expressed and secreted 
Runx2  Runt-related transcription factor 2 
S. aureus Staphylococcus aureus 
sCD  Soluble cluster of differentiation 
SDF-1  Stromal cell-derived factor 1 
S. pyogenes Streptococcus pyogenes 
SVF  Stromal vascular fraction 
TAK  Transforming growth factor beta-activated kinase 
TLR  Toll-like receptor 
TNF() Tumor necrosis factor (alpha) 
TRAF  TNF receptor associated factor 
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